Medicenna Therapeutics Corp. Tech Stack

Medicenna Therapeutics Corp. uses 8 technology products and services including Drupal, NextAuth.js, Google Cloud, and more. Explore Medicenna Therapeutics Corp.'s tech stack below.

Drupal

Content Management System

NextAuth.js

Identity Verification

Google Cloud

Infrastructure As A Service

Vercel

Platform As A Service

Acquia Cloud Platform

Platform As A Service

CKEditor

Rich Text Editors

Akamai Bot Manager

Security

Adobe Tag Manager

Tag Management

Medicenna Therapeutics Corp. Email Formats	Example	Percentage
FLast@medicenna.com	JDoe@medicenna.com	71%
First@medicenna.com	John@medicenna.com	23%
Last@medicenna.com	Doe@medicenna.com	3%
First.Last@medicenna.com	John.Doe@medicenna.com	3%

Medicenna Therapeutics Corp. Email Formats

Example

Percentage

FLast@medicenna.com

JDoe@medicenna.com

71%

First@medicenna.com

John@medicenna.com

23%

Last@medicenna.com

Doe@medicenna.com

First.Last@medicenna.com

John.Doe@medicenna.com

Frequently Asked Questions

Where is Medicenna Therapeutics Corp.'s headquarters located?

Medicenna Therapeutics Corp.'s main headquarters is located at 2 Bloor Street West Toronto, Ontario Canada. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Medicenna Therapeutics Corp.'s phone number?

You can contact Medicenna Therapeutics Corp.'s main corporate office by phone at

+1-416-648-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Medicenna Therapeutics Corp.'s official website and social media links?

Medicenna Therapeutics Corp.'s official website is medicenna.com and has social profiles on LinkedIn.

What is Medicenna Therapeutics Corp.'s SIC code NAICS code?

Medicenna Therapeutics Corp.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Medicenna Therapeutics Corp. have currently?

As of June 2026, Medicenna Therapeutics Corp. has approximately 24 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: D. H.Vp Of Oncology Research: M. D. T.President And Ceo: F. M.. Explore Medicenna Therapeutics Corp.'s employee directory with LeadIQ.

What industry does Medicenna Therapeutics Corp. belong to?

Medicenna Therapeutics Corp. operates in the Biotechnology Research industry.

What technology does Medicenna Therapeutics Corp. use?

Medicenna Therapeutics Corp.'s tech stack includes DrupalNextAuth.jsGoogle CloudVercelAcquia Cloud PlatformCKEditorAkamai Bot ManagerAdobe Tag Manager.

What is Medicenna Therapeutics Corp.'s email format?

Medicenna Therapeutics Corp.'s email format typically follows the pattern of FLast@medicenna.com. Find more Medicenna Therapeutics Corp. email formats with LeadIQ.

Medicenna Therapeutics Corp.

Q: How many employees does Medicenna Therapeutics Corp. have currently?

Medicenna Therapeutics Corp. has approximately 24 employees.

Q: What technology does Medicenna Therapeutics Corp. use?

Medicenna Therapeutics Corp.'s tech stack includes NextAuth.js, Web Vitals, reCAPTCHA, Moment.js, Google Tag Manager.

Q: What is Medicenna Therapeutics Corp.'s NAICS code?

Medicenna Therapeutics Corp.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchOntario, Canada11-50 Employees

Medicenna Therapeutics Corp. is a clinical-stage biotechnology company based in Toronto, Ontario, focused on developing immunotherapies for cancer and inflammatory diseases. It works on engineered cytokines designed to broaden treatment options by modulating the immune system. Lead programs include Bizaxofusp for glioblastoma, an IL-2–targeting therapy for metastatic cancers, and a PD-1 x IL-2 bispecific aimed at cancers expressing IL-13Rα2, with early-stage programs in autoimmune conditions such as asthma and COPD.

The therapies are intended for patients with cancer or autoimmune/inflammatory diseases and the clinicians who care for them. Medicenna operates within the biotechnology research industry and pursues global clinical development from its Toronto base. In 2026, Medicenna presented preclinical data at the AACR Annual Meeting.

Insights

Similar companies to Medicenna Therapeutics Corp.

AFFiRiS AG

BioNTech SE